Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, this warning letter was issued to Global Treat Srl, a drug manufacturer, on March 31, 2020. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The letter falls under FDA's drug regulation authority, though the specific issuing office is not identified in the metadata provided. To understand the complete regulatory concerns and required corrective actions, access to the full warning letter would be necessary.